Latest filing published 24 Aug 2026 for Standard Biotools INC., €56k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Michael Egholm on record concern Standard Biotools Inc. Between 4 April 2023 and 20 August 2026, the trades on record add up to 22 filings.
Sales make up the whole of the open-market record (2 sales, €9,109). The rest of the record consists of 17 share grants and 3 option exercises.
The newest entry dates from 24 August 2026: a share grant of €56k, in Standard Biotools Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations